Is ZBH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ZBH. It does not provide personalized investment advice.

ZBH (Zimmer Biomet) Stock Analysis - Financials

Zimmer Biomet (ZBH) is a publicly traded Healthcare sector company. As of August 28, 2026, ZBH trades at $100.73 with a market cap of $18.97B and a P/E ratio of 24.44. ZBH moved +1.44% today. Year to date, ZBH is +12.10%; over the trailing twelve months it is -3.95%. Its 52-week range spans $79.12 to $114.44. Analyst consensus is buy with an average price target of $106.07. Rallies surfaces ZBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ZBH's key financials?

ZBH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ZBH recently traded at $100.73. Market cap is $18.97B. P/E ratio is 24.44. Revenue is $8.51B.

ZBH Key Metrics

Key financial metrics for ZBH
Metric	Value
Price	$100.73
Market Cap	$18.97B
P/E Ratio	24.44
EPS	$4.13
Dividend Yield	0.24%
52-Week High	$114.44
52-Week Low	$79.12
Volume	773.23K
Avg Volume	0
Revenue (TTM)	$8.51B
Net Income	$807.00M
Gross Margin	69.87%

ZBH Analyst Consensus

18 analysts cover ZBH: 0 strong buy, 6 buy, 12 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $106.07.

Common questions about ZBH

What are ZBH's key financials?: ZBH financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ZBH recently traded at $100.73. Market cap is $18.97B. P/E ratio is 24.44. Revenue is $8.51B.
Is ZBH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ZBH. It does not provide personalized investment advice.